Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

An addax had skin cancer that spread to lymph nodes and was euthanized.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.

A rare type of skin lymphoma was identified, affecting hair follicles and sweat glands.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

Blocking autophagy increases survival of inner ear hair cells exposed to gentamicin.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.